InvestorsHub Logo
Followers 52
Posts 5329
Boards Moderated 0
Alias Born 09/16/2013

Re: HappyLibrarian post# 357973

Friday, 02/26/2021 3:10:36 PM

Friday, February 26, 2021 3:10:36 PM

Post# of 703777
HappyLibrarian,

Correct Cognate is not NWBO. But everyone knows Cognate has been the manufacturer of DCVax-L for the Phase3 trial. Cognate has the most extensive knowledge of the DCVax-L development/manufacturing process and you know full well that NWBO essentially paid for its expansion. Regardless of what other clients Cognate has, given (1) the journal data released and signed off on by 69 oncologists and other medical experts, (2) the changes in trial endpoints announced by the RA agencies on the other side of the pond, (3) the build out of Advent Bioservices and (4) The ability of Cognate to now easily scale up the commercial manufacturing and distribution of DCVax-L if it is approved (keep in mind that NWBO's product IS the manufacturing process), the CRL/Cognate news is EXTREMELY positive and positions NWBO nicely for its commercialization phase.

If I let go of a hammer on a planet that has a positive gravity, I need not see it fall to know that it has in fact fallen-- Mr. Spock





The only thing necessary for the triumph of evil is for good men to do nothing. We live in a time where too many go beyond doing nothing, they boast about their evil deeds and thank their always-loving God for the opportunity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News